Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.49 |
| ▸ | UNG | P13051 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMO | O15229 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29420736 | 1.00 | SRD5A2 (0.57) | SRD5A2CES2AKR1C3AKR1C2UNG | |
| SCHEMBL8922389 | 0.85 | AKR1C3 (0.63) | SRD5A2AKR1C3MRGPRX4NR4A2KMO | |
| SCHEMBL5115473 | 0.85 | SRD5A2 (0.62) | SRD5A2CES2AKR1C3AKR1C2UNG | |
| SCHEMBL40186 | 0.84 | SRD5A2 (0.77) | SRD5A2CES2AKR1C3AKR1C2MRGPRX4 | |
| SCHEMBL29433907 | 0.84 | SRD5A2 (0.77) | SRD5A2CES2AKR1C3AKR1C2MRGPRX4 | |
| SCHEMBL4613288 | 0.84 | SRD5A2 (0.61) | SRD5A2CES2AKR1C3AKR1C2UNG | |
| SCHEMBL25955784 | 0.84 | SRD5A2 (0.43) | SRD5A2CES2AKR1C3AKR1C2UNG | |
| SCHEMBL8775382 | 0.83 | CES2 (0.52) | SRD5A2CES2ACHELMNAHPGD | |
| Hydrochloric Acid SCHEMBL10387616 | 0.82 | SRD5A2 (0.74) | SRD5A2CES2AKR1C3AKR1C2MRGPRX4 | |
| Hydrochloric Acid SCHEMBL30596522 | 0.82 | SRD5A2 (0.74) | SRD5A2CES2AKR1C3AKR1C2MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035512-A1 | POLYAMIDES AND CORRESPONDING POLYMER COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING | SYENSQO SPECIALTY POLYMERS USA, LLC (US) | 2026-02-05 | — | — | US | claimed |
| US-12473402-B2 | Polyamides and corresponding polymer compositions, articles and methods for making and using | SYENSQO SPECIALTY POLYMERS USA, LLC (US) | 2025-11-18 | — | — | US | claimed |
| EP-4276136-B1 | POLYAMIDES AND CORRESPONDING POLYMER COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING | SYENSQO SPECIALTY POLYMERS USA LLC (US) | 2025-11-12 | — | — | EP | claimed |
| EP-4633909-A1 | OVERMOLDED PLASTIC ARTICLES, USES THEREOF, METHOD OF MAKING | Syensqo Specialty Polymers USA, LLC (US) | 2025-10-22 | — | — | EP | claimed |
| US-12378357-B2 | Polyamides and corresponding polymer compositions and articles | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2025-08-05 | — | — | US | claimed |
| US-12247099-B2 | Process for preparing particles of polyphenylene sulfide polymer | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2025-03-11 | — | — | US | claimed |
| WO-2024125972-A1 | OVERMOLDED PLASTIC ARTICLES, USES THEREOF, METHOD OF MAKING | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2024-06-20 | — | — | WO | claimed |
| US-20240182635-A1 | PROCESS FOR PREPARING PARTICLES OF POLYPHENYLENE SULFIDE POLYMER | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2024-06-06 | — | — | US | claimed |
| US-11905364-B2 | Process for preparing particles of polyphenylene sulfide polymer | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2024-02-20 | — | — | US | claimed |
| EP-3559081-B1 | GLYCOLIC ACID POLYMER | SOLVAY (BE) | 2023-11-22 | — | — | EP | claimed |
| WO-2021037850-A1 | POLYAMIDES AND CORRESPONDING POLYMER COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| WO-2020229318-A1 | POLYAMIDES AND CORRESPONDING POLYMER COMPOSITIONS AND ARTICLES | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2020-11-19 | — | — | WO | claimed |
| US-20200190255-A1 | GLYCOLIC ACID POLYMER | SYENSQO SA (BE) | 2020-06-18 | — | — | US | claimed |
| EP-3559081-A1 | GLYCOLIC ACID POLYMER | Solvay SA (BE) | 2019-10-30 | — | — | EP | claimed |
| WO-2018115008-A1 | GLYCOLIC ACID POLYMER | SOLVAY SA (BE) | 2018-06-28 | — | — | WO | claimed |
| US-20160108174-A1 | POLYAMIDES COMPRISING ME-BHT, COMPOSITIONS COMPRISING SUCH A POLYAMIDE, SHAPED ARTICLES COMPRISING SUCH A POLYAMIDE OR SUCH A COMPOSITION | PERFORMANCE POLYAMIDES, SAS (FR) | 2016-04-21 | — | — | US | claimed |
| EP-3004210-A1 | POLYAMIDES COMPRISING ME-BHT, COMPOSITIONS COMPRISING SUCH A POLYAMIDE, SHAPED ARTICLES COMPRISING SUCH A POLYAMIDE OR SUCH A COMPOSITION | Rhodia Opérations S.A.S. (FR) | 2016-04-13 | — | — | EP | claimed |
| WO-2014191303-A1 | POLYAMIDES COMPRISING ME-BHT, COMPOSITIONS COMPRISING SUCH A POLYAMIDE, SHAPED ARTICLES COMPRISING SUCH A POLYAMIDE OR SUCH A COMPOSITION | RHODIA OPERATIONS (FR) | 2014-12-04 | — | — | WO | claimed |
| EP-0397022-A2 | Polyimide-Polyamide polymers having fluorine-containing linking groups | HOECHST CELANESE CORPORATION (US) | 1990-11-14 | — | — | EP | claimed |
| US-4962183-A | HEAT, OXIDATION AND SOLVENT RESISTANCE; MOLDING MATERIALS; MELT PROCESSIBILITY; FIBERS, FILMS AND SHEETS | HOECHST CELANESE CORP. (US) | 1990-10-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035512-A1 | POLYAMIDES AND CORRESPONDING POLYMER COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING | ABHD6, DDC, SLC16A8 | SRD5A2 4007/4885CES2 591/4885AKR1C3 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.